Clinical Decision Support Systems (CDSS) Market Overview 2023-2028

The global clinical decision support systems (CDSS) market size reached US$ 1.50 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.36 Billion by 2028, exhibiting a CAGR of 7.70% during 2023-2028. The increasing demand for service-oriented intelligent healthcare decision-making software and the rising instances of medical errors represent some of the key factors driving the market.

Clinical decision support systems (CDSS) are specialized computer-based applications that are tailored to analyze data within electronic health records (EHR) systems. They can be broadly classified into two categories: integrated systems and standalone products, and they utilize a variety of software and hardware solutions. CDSS services are designed to effectively store and manage vast amounts of clinical and administrative data. They also provide reminders to clinicians, staff, and physicians, suggesting improved clinical treatments to ensure optimal patient care. These systems enhance healthcare delivery by leveraging targeted clinical information to make complex medical decisions, streamline workflows, reduce the risk of medication errors, minimize misdiagnoses, and assist in performing various administrative tasks. As a result, CDSS solutions are extensively utilized in healthcare facilities worldwide.

Clinical Decision Support Systems (CDSS) Market Trends and Drivers:

The clinical decision support systems (CDSS) market is experiencing significant growth due to several key factors. One of the primary drivers is the increasing demand for advanced systems featuring specialized algorithms, service-oriented architectures, and interactive interfaces to address various chronic disorders. Additionally, the market is benefiting from the rising instances of medication errors caused by human intervention, highlighting the need for more efficient solutions that can enhance clinical decision-making. Government initiatives aimed at promoting the adoption of health information and communication technology (HICT) in healthcare settings are playing a crucial role in boosting the market. These initiatives aim to provide healthcare workers with reliable data, enabling them to deliver high-quality care to patients at lower costs. Furthermore, the integration of artificial intelligence (AI), machine learning (ML), statistical pattern recognition solutions, and computerized provider order entry (CPOE) into CDSS systems is a growing trend that is driving market growth. These technologies enable the analysis of data measurements to extract valuable information, improving the capabilities of CDSS.

Global Clinical Decision Support Systems (CDSS) Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Athenahealth Inc., Change Healthcare (United Health Group Incorporated), Epic Systems Corporation, General Electric Company, International Business Machines Corporation, Koninklijke Philips N.V., NextGen Healthcare Inc., Oracle Corporation, Siemens Healthineers AG (Siemens AG), Wolters Kluwer N.V., Zynx Health Incorporated (Hearst Business Media Corporation), etc.

The report has segmented the market on the basis of region, component, product, type, delivery mode, model, and application.

Component Insights

• Hardware
• Software
• Services

The report has provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the component. This includes hardware, software and services. According to the report, services represented the largest segment.

Product Insights

• Integrated CDSS
• Standalone CDSS

A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the product has also been provided in the report. This includes integrated and standalone CDSS. According to the report, integrated CDSS accounted for the largest market share.

Type Insights

• Therapeutic
• Diagnostic

The report has also provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the type. This includes therapeutic and diagnostic. According to the report, therapeutic represented the largest segment.

Delivery Mode Insights

• On Premise
• Cloud Based

A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the delivery mode has also been provided in the report. This includes on premise and cloud based. According to the report, on-premise accounted for the largest market share.

Model Insights

• Knowledge Based
• Non-Knowledge Based

The report has also provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the model. This includes knowledge and non-knowledge based. According to the report, knowledge based represented the largest segment.

Application Insights

• Drug Allergy Alerts
• Clinical Guidelines
• Drug-Drug Interactions
• Clinical Reminders
• Others

A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the application has also been provided in the report. This includes drug allergy alerts, clinical guidelines, drug-drug interactions, clinical reminders and others. According to the report, drug allergy alert accounted for the largest market share.

Regional Insights

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for clinical decision support systems. Some of the factors driving the North America clinical decision support system market included the increasing demand for service-oriented intelligent healthcare decision-making software and the rising instances of medical errors.

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800